These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20105129)
1. Latest advancements on serotonin and dopamine transporters in lymphocytes. Marazziti D; Consoli G; Masala I; Catena Dell'Osso M; Baroni S Mini Rev Med Chem; 2010 Jan; 10(1):32-40. PubMed ID: 20105129 [TBL] [Abstract][Full Text] [Related]
2. Snapshot of antidepressants at work: the structure of neurotransmitter transporter proteins. Cuboni S; Hausch F Angew Chem Int Ed Engl; 2014 May; 53(20):5008-9. PubMed ID: 24729171 [TBL] [Abstract][Full Text] [Related]
3. Emerging structure-function relationships defining monoamine NSS transporter substrate and ligand affinity. Wang CI; Lewis RJ Biochem Pharmacol; 2010 Apr; 79(8):1083-91. PubMed ID: 19954741 [TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Numachi Y; Ohara A; Yamashita M; Fukushima S; Kobayashi H; Hata H; Watanabe H; Hall FS; Lesch KP; Murphy DL; Uhl GR; Sora I Eur J Pharmacol; 2007 Oct; 572(2-3):120-8. PubMed ID: 17673199 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures. Zhou Z; Zhen J; Karpowich NK; Law CJ; Reith ME; Wang DN Nat Struct Mol Biol; 2009 Jun; 16(6):652-7. PubMed ID: 19430461 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters. Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177 [TBL] [Abstract][Full Text] [Related]
7. The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-Hooded rats: a quantitative autoradiography study. Chen F; Lawrence AJ Brain Res; 2003 Jun; 976(1):22-9. PubMed ID: 12763618 [TBL] [Abstract][Full Text] [Related]
8. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors. Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503 [TBL] [Abstract][Full Text] [Related]
17. Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands. Andersen J; Ladefoged LK; Kristensen TN; Munro L; Grouleff J; Stuhr-Hansen N; Kristensen AS; Schiøtt B; Strømgaard K ACS Chem Neurosci; 2016 Oct; 7(10):1406-1417. PubMed ID: 27425420 [TBL] [Abstract][Full Text] [Related]
18. Interactions of serotonin reuptake inhibitors with tricyclic antidepressants. Harvey AT; Preskorn SH Arch Gen Psychiatry; 1995 Sep; 52(9):783-5. PubMed ID: 7654130 [No Abstract] [Full Text] [Related]
19. Thiophene derivatives: a new series of potent norepinephrine and serotonin reuptake inhibitors. Zhang A; Zhou G; Rong SB; Johnson KM; Zhang M; Kozikowski AP Bioorg Med Chem Lett; 2002 Apr; 12(7):993-5. PubMed ID: 11909701 [TBL] [Abstract][Full Text] [Related]
20. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Kugaya A; Seneca NM; Snyder PJ; Williams SA; Malison RT; Baldwin RM; Seibyl JP; Innis RB Neuropsychopharmacology; 2003 Feb; 28(2):413-20. PubMed ID: 12589396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]